About Bio-Synthesis
Bio-Synthesis is a Healthcare company based in Lewisville (United States) founded in 1984. It operates as a service provider of custom and catalog peptides, custom oligos, nucleic acids, antibodies, organic synthesis and bioanalytical services. Its website biosyn.com draws about 41 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its competitors include Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and IRBM and 3 more; 2 of its 8 listed competitors have raised funding.
Company details
Bio-Synthesis is a life sciences company that provides synthesis services related to peptides, oligos, bridged nucleic acids, antibodies and bioconjugation. Besides, it also provides bioanalytical services like cell line authentication, protein characterization; molecular biology services like gene synthesis, mutagenesis; and protein services like protein expression, purification. It also develops catalogue peptides for Alzheimer, Breast cancer, EBV infections, HIV and epigenetics and also purification kits for DNA, RNA and proteins.
- Headquarters Lewisville, United States
- SectorsHealthcare
- Email••••••••
- Website biosyn.com
- Social LinkedIn Facebook
- Latest Funding Round$590.21K (USD), Grant
Feb 2010
- Investors
Funding Insights of Bio-Synthesis
- Total Rounds 2
- Last Round Grant — $590,207
- First Round $590,207
(Feb 2010)
- Investors Count 1
All 2 funding rounds of Bio-Synthesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Bio-Synthesis
Bio-Synthesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Bio-Synthesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bio-Synthesis
3 dated milestones of Bio-Synthesis across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Bio-Synthesis is founded.
- Funding First funding round of $590K.
- Funding Latest funding round, Grant, of $590K.
Competitors of Bio-Synthesis
Bio-Synthesis has 8 listed competitors in our database, 2 of them funded. They include Sai Life Sciences, Acies Bio, Personal Chemistry, NFIL and IRBM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | |
| nfil.in | 1967 | Mumbai, India | – | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | |
| irbm.com | 2010 | Pomezia, Italy | – | – | Integrated drug discovery and preclinical development services are provided. | |
| medicilon.com | 2004 | Pudong, China | – | – | Integrated drug discovery and preclinical services are provided. | |
| bioduro.com | 2005 | San Diego, United States | – | – | Integrated drug discovery and development services | |
| spirochem.com | 2011 | Zurich, Switzerland | – | – | Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry |
Detailed competitors of Bio-Synthesis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio-Synthesis
The website of Bio-Synthesis (biosyn.com) receives about 41K visits a month.
- Monthly visits41K
▼ 10.6% vs previous month
Websites whose visitors overlap most with Bio-Synthesis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioatla.com | 100% | 15.1K | #1,740,050 | View details | |
| dalton.com | 100% | 4.8K | #3,789,431 | View details | |
| genelink.com | 98% | 10.8K | #2,265,843 | View details | |
| exonbio.com | 95% | 4K | #4,969,058 | View details | |
| vizgen.com | 88% | 20.3K | #1,392,149 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Bio-Synthesis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Bio-Synthesis (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bio-Synthesis
Bio-Synthesis was founded in 1984 and raised its 1st funding round 26 years after it was founded.
Bio-Synthesis is headquartered in Lewisville, United States. It is registered at Lewisville, Texas, United States.
Bio-Synthesis is a life sciences company that provides synthesis services related to peptides, oligos, bridged nucleic acids, antibodies and bioconjugation. Besides, it also provides bioanalytical services like cell line authentication, protein characterization; molecular biology services like gene synthesis, mutagenesis; and protein services like protein expression, purification. It also develops catalogue peptides for Alzheimer, Breast cancer, EBV infections, HIV and epigenetics and also purification kits for DNA, RNA and proteins.
Bio-Synthesis's top competitors include Sai Life Sciences, Acies Bio and Medicilon.
Bio-Synthesis has 1 investor. Key investors include HHS.